These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38850461)

  • 1. Patient-reported burden in adults with atopic dermatitis: an international qualitative study.
    Wollenberg A; Gooderham M; Katoh N; Aoki V; Pink AE; Binamer Y; Silverberg JI
    Arch Dermatol Res; 2024 Jun; 316(7):380. PubMed ID: 38850461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
    Silverberg JI; Gooderham MJ; Paller AS; Deleuran M; Bunick CG; Gold LFS; Hijnen D; Calimlim BM; Lee WJ; Teixeira HD; Hu X; Zhang S; Yang Y; Grada A; Platt AM; Thaçi D
    Am J Clin Dermatol; 2024 May; 25(3):485-496. PubMed ID: 38528257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis.
    Dainty KN; Thibau IJC; Amog K; Drucker AM; Wyke M; Begolka WS
    Br J Dermatol; 2024 Jun; 191(1):82-91. PubMed ID: 38287887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis.
    Bacci E; Rentz A; Correll J; Pierce E; DeLozier A; Rueda M; Begolka W; Butler L
    J Drugs Dermatol; 2021 Nov; 20(11):1222-1230. PubMed ID: 34784136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K; Funk M; Hering M; Lang J; Merhand S; Manion R; Orevillo K; Picozza M; Proctor A; Schwennesen T; Begolka WS; Tullos K; Talent C; Tu M; Vastrup AS; Schwartz A
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):264-273.e1. PubMed ID: 36332836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT).
    Pariser DM; Simpson EL; Gadkari A; Bieber T; Margolis DJ; Brown M; Nelson L; Mahajan P; Reaney M; Guillemin I; Mallya UG; Eckert L
    Curr Med Res Opin; 2020 Mar; 36(3):367-376. PubMed ID: 31778083
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
    Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
    JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS).
    Silverberg JI; Leshem YA; Calimlim BM; McDonald J; Litcher-Kelly L
    Curr Med Res Opin; 2023 Oct; 39(10):1289-1296. PubMed ID: 37691437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.
    Silverberg JI; Thyssen JP; Simpson EL; Yosipovitch G; Ständer S; Valdez H; Rojo R; Biswas P; Myers DE; Feeney C; DiBonaventura M
    Am J Clin Dermatol; 2021 Jul; 22(4):541-554. PubMed ID: 33954933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
    Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Tajima Y; Ardeleanu M; Rizova E; Arima K;
    J Dermatol; 2019 Apr; 46(4):290-300. PubMed ID: 30756423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement properties of three assessments of burden used in atopic dermatitis in adults.
    Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; Kantor R; Hsu DY; Silverberg JI
    Br J Dermatol; 2019 May; 180(5):1083-1089. PubMed ID: 30246360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
    Iannone M; Tonini G; Janowska A; Dini V; Romanelli M
    Curr Med Res Opin; 2021 Aug; 37(8):1295-1301. PubMed ID: 34027753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    Simpson EL; Gadkari A; Worm M; Soong W; Blauvelt A; Eckert L; Wu R; Ardeleanu M; Graham NMH; Pirozzi G; Sutherland ER; Mastey V
    J Am Acad Dermatol; 2016 Sep; 75(3):506-515. PubMed ID: 27268421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY; Chiesa Fuxench ZC
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):340-347. PubMed ID: 30025911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical Care.
    Maintz L; Bieber T; Bissonnette R; Jack C
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1473-1486.e2. PubMed ID: 33838840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Characterization of Patients With Atopic Dermatitis in Portugal: The QUADEP Study.
    Carvalho D; Aguiar P; Mendes-Bastos P; Palma-Carlos A; Freitas J; Ferrinho P
    J Investig Allergol Clin Immunol; 2020; 30(6):430-438. PubMed ID: 31530518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.
    Ramessur R; Dand N; Langan SM; Saklatvala J; Fritzsche MC; Holland S; Arents BWM; McAteer H; Proctor A; McMahon D; Greenwood M; Buyx AM; Messer T; Weiler N; Hicks A; Hecht P; Weidinger S; Ndlovu MN; Chengliang D; Hübenthal M; Egeberg A; Paternoster L; Skov L; De Jong EMGJ; Middelkamp-Hup MA; Mahil SK; Barker JN; Flohr C; Brown SJ; Smith CH
    Br J Dermatol; 2024 Jun; 191(1):14-23. PubMed ID: 38419411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' and Caregivers' Experiences Navigating the Burden of Atopic Dermatitis in Argentina.
    Capozza K; Tu M; Schwartz A; Johnson JL; Ladner M
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674230
    [No Abstract]   [Full Text] [Related]  

  • 20. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life.
    Ali F; Vyas J; Finlay AY
    Acta Derm Venereol; 2020 Jun; 100(12):adv00161. PubMed ID: 32412644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.